Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07530965
NA
Omega-3-Fatty Acids in Children With Sickle Cell Disease
Sponsor: University of Alabama at Birmingham
View on ClinicalTrials.gov
Summary
The purpose of this feasibility study is to investigate the role of a dietary supplement in modulating the gut microbiota and improving pain outcomes in children with sickle cell disease (SCD).
Official title: A Single Arm/ Open Label Feasibility Trial of Omega-3- Fatty Acids in Children With Sickle Cell Disease
Key Details
Gender
All
Age Range
5 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-12-01
Completion Date
2029-06-30
Last Updated
2026-08-21
Healthy Volunteers
No
Conditions
Interventions
DIETARY_SUPPLEMENT
Flaxseed
Flaxseed